V12 SENTINEL ENGINE
All AI Trading Journal Entries
FAILED
#DBVT#VIASKIN#FDA#BLA
DBVTAI Trading Journal · 2026-10-31

The limit of a rebound that failed to read hidden bad news amid expectations

DBV expects cash runway into Q3 2027 as it advances sequential FDA reviews for VIASKIN Peanut BLAs

ENTRY PRICE$10.65Entry reference price
AI PREDICTION+4.5%Predicted upside
VERIFIED RESULT-10.9%10.9% down
PREDICTION GAP-15.4%pGap vs. actual result
CONFIDENCE76AI analysis confidence
01
CATALYST SUMMARY

What was the news?

View Original ↗

DBV Technologies가 VIASKIN Peanut BLA에 대한 순차적 FDA 심사를 진행하면서 2027년 3분기까지 현금 보유고를 확보할 것으로 예상된다는 내용입니다.

02
INITIAL SCENARIO

AI's Initial Call

Entry Rationale

현재가 $10.65가 20일 저점($8.63)과 고점($12.21) 사이의 중간 구간에 위치하고, 거래량이 20일 평균 대비 1.49배로 실리며 최근 7일간 +11.9%의 변동률을 기록한 반등 흐름을 보이고 있어 진입을 고려합니다.

Target/Stop Scenario

If the rebound with increased volume continues and reaches the resistance level around $12.21, I will take profit; if the downside support level at $8.63 breaks, I will cut losses. The current price of $10.65 is situated between the 20-day low ($8.63) and high ($12.21), and we need to monitor whether it breaks through the resistance level.

Take-profit reference$12.21
Stop-loss reference$8.63
03
TECHNICAL BASELINE

Market Data at Analysis Time

RSI56.0
Vs. Average Volume1.49×
Recent Change+11.9%
MA20$9.81MA60$12.16MA200$17.06

RSI(14) 56.0, moving average misalignment, trading volume 1.49 times the 20-day average, has recorded a 7-day change of +11.9%.

AI LEARNING NOTE

Reviewing Prediction vs. Actual Result

FDA 심사 진행과 현금 확보 기대감으로 거래량이 실린 반등 흐름(+11.9%, 20일 평균 대비 1.49배)을 보이며 저항선 돌파를 기대했으나, 실제 결과는 -10.9%의 손실을 기록하며 FAILED 판정을 받았습니다. 진입 시점에는 비정배열 이평선과 중간 가격대($10.65)에서의 반등 모멘텀에 집중했으나, 같은 기간 전후로 제기된 going-concern 경고 및 3분기 손실 확대 같은 잠재적 리스크 요인이 하방 압력으로 작용하는 과정을 충분히 방어하지 못했습니다.

What to Watch in the Next Analysis

Through this trade, rather than relying solely on short-term volume surges and positive news, we will establish a conservative criterion to review concurrent financial risks and warning disclosures together. Going forward, we will respond by more strictly factoring in the risk of breaking support near the stop-loss price ($8.63).

05
V13 VERIFICATION

Chart Verification

V13 Worker auto-verified
Initial ChartAt Analysis · 2026-10-31
$10.65
Verification ChartVerification · 2026-10-31 09:02:12
-10.9%
Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.